-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on CERo Therapeutics Hldgs, Maintains $30 Price Target

Benzinga·09/09/2025 12:41:27
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price target.